Obesity Trial, Recruiting NCT05464186 Sponsor: Boston Children's Hospital Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05464186
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 9 and 12 years old
  • Children whose BMI (a measure of body weight relative to height) is at or above the 75th percentile for their age and sex
  • Children who live in the Greater Boston area

Who may not be able to join:

  • Children who dislike or refuse to drink nonfat or whole milk
  • Children who have been diagnosed by a doctor with a serious medical condition, an eating disorder, or a milk allergy (note: lactose intolerance alone does not automatically prevent participation, as specially treated milk may be available — confirm with trial site)
  • Children who have plans to move out of the Greater Boston area during the study
  • Children who will be away from home for 5 weeks or more during the study period (for example, due to an extended summer vacation)
  • Children whose body weight changed by more than 10% in the past year
  • Children who have recently been following a special or restricted diet
  • Children who regularly take any medication or dietary supplement that could affect the study results
  • Children who have a close family member (parent, sibling) or someone in the same household who is already participating in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cara B Ebbeling, PhD, Boston Children's Hospital

Phone: 617-919-7305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston Children's Hospital
Registry
ClinicalTrials.gov
Start date
28 December 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fat mass

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov